Brief: Lipigon Pharmaceuticals Announces Notice Of Allowance For Patent Application
08/06/2023 10:30
June 8 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* US PATENT AND TRADEMARK OFFICE HAS ISSUED NOTICE OF
ALLOWANCE
FOR CO'S PATENT APPLICATION COVERING LIPISENSE FOR TREATMENT OF
CARDIOMETABOLIC DISEASE
* ONCE GRANTED, PATENT WILL BE VALID UNTIL 2039
Source text for Eikon: ID:nBQN2S1Mhk
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds